An FTC official said the case argues that PBMs ... a report refuting arguments that the industry raises costs. The drug middlemen say they’re a necessary counterweight to the unchecked ...
The drug middlemen say they’re a necessary counterweight to the unchecked power of pharmaceutical companies to set prices. The insulin market is dominated by three manufacturers: Eli Lilly & Co., ...
endangering patients,” said the FTC's Chair, Lina Khan. “Our inquiry requests information on the factors driving these shortages and scrutinises the practices of opaque drug middlemen.” ...
Evidence also suggests that some of the prescription drug rebates negotiated ... “I’m proud that the FTC launched a bipartisan investigation into these shadowy middlemen, and its preliminary ...
The owner of one of the three largest pharmacy middlemen in the United States last month filed suit to quash an attempt by the Federal Trade Commission to investigate industry ...
But they have prioritized becoming more than middlemen by also becoming cancer care providers. Just as in other parts of health care that are vertically integrated, there is a large opportunity to ...
The FTC received an average of 21 complaints per day about this issue in 2021, the agency has written. The number was 70 per day by 2024. The Biden administration began working on this policy in ...